Physician profile
Ronald Sam
NPI 1073537643
$495.35
in general payments reported to CMS, 2019-2025
10 companies · $52.94 in 2025
The $52.94 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.54 · 2021: $67.52 · 2022: $219 · 2023: $62.95 · 2024: $35.42 · 2025: $52.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $112.88 | 2021-2022 | |
| Almatica Pharma LLC | $78.73 | 2022-2023 | Loreev Xr |
| Novo Nordisk INC | $65.22 | 2021-2025 | Ozempic, Rybelsus |
| Watermark Medical, INC. | $43.00 | 2022 | |
| Pfizer INC. | $37.55 | 2021 | |
| Abbott Laboratories | $35.99 | 2022 | |
| Aimmune Therapeutics, INC. | $35.42 | 2024 | |
| Smith+Nephew, INC. | $29.98 | 2019 | |
| Edwards Lifesciences Corporation | $29.02 | 2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $27.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Sam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.